Insights on where healthcare gaps create opportunity
Exploring the ideas, innovations, and healthcare system changes shaping better decisions, better care, and better adoption.
Explore news and insights below
Public grant propels an early bet on continuous hormone sensing — why investors should pay attention
An Estonia-based femtech startup has won a €700K public grant to advance a wearable patch that samples interstitial fluid for multiple daily hormone readings; the award de-risks core sensor work but leaves clinical and commercial hurdles ahead. For investors, the key questions are technical validation of the bioselective layer, regulatory pathway choices, and whether continuous hormone data creates durable clinical and consumer demand.
Small seed, strategic signal: Chiron’s AI self‑management platform positions continuous care as a playbook for women’s health gaps
A £900K seed and an NHS‑ready technical build make Chiron a capital‑efficient early bet on multi‑condition, n‑of‑1 digital self‑management — an approach that could unlock female‑presentation clinical gains if it proves durable at scale.
ESHRE 2026: A turning point — IVF effectiveness is rising while cost and environment become the new bottlenecks
Clinical outcomes presented at ESHRE show modern lab practice has decoupled single-embryo transfer from lower success rates, shifting the commercial opportunity from embryo-number to cost, uterine health, and environmental diagnostics. Investors should reweight toward technologies that cut per-baby cost, expand FET capacity, and address non-oocyte biological risks.
Why Holistic Medicine Is Returning to the Center of Women's Health in Africa
OURbody founder Chelsea Jambo on why the remedies women passed down for generations were never a quaint alternative to medicine — they were filling gaps a research system built on non-African, non-female bodies never closed.
McKinsey: Closing the UK's Women's Health Gap Is a £36 Billion Opportunity
A new McKinsey Health Institute report puts a hard number on what Fern has argued since day one: UK women spend 24% more time in poor health than men, and closing that gap could add £36 billion a year to the economy by 2040.
The Digital Midwife: How Malaica Blends Tech Care with a Human Touch for Expectant Mums
Malaica founder Dr. Lorraine Muluka on why she built a hybrid maternal health platform around a 24/7 nurse-midwife line and a human care team, not a chatbot — and why the postpartum "fourth trimester" gets the same clinical attention as pregnancy itself.
Impli Awarded £1.4M NIHR Grant to Advance World-First Continuous Hormone Monitoring Patch for Infertility Treatment
The award will fund a 30-month consortium programme bringing together Impli, Imperial College Healthcare NHS Trust, King's College London, and Fertility Europe to take the BEAM biosensor from prototype to first-in-human clinical validation.
Public grant propels an early bet on continuous hormone sensing — why investors should pay attention
An Estonia-based femtech startup has won a €700K public grant to advance a wearable patch that samples interstitial fluid for multiple daily hormone readings; the award de-risks core sensor work but leaves clinical and commercial hurdles ahead. For investors, the key questions are technical validation of the bioselective layer, regulatory pathway choices, and whether continuous hormone data creates durable clinical and consumer demand.
Read more →Small seed, strategic signal: Chiron’s AI self‑management platform positions continuous care as a playbook for women’s health gaps
A £900K seed and an NHS‑ready technical build make Chiron a capital‑efficient early bet on multi‑condition, n‑of‑1 digital self‑management — an approach that could unlock female‑presentation clinical gains if it proves durable at scale.
Read more →ESHRE 2026: A turning point — IVF effectiveness is rising while cost and environment become the new bottlenecks
Clinical outcomes presented at ESHRE show modern lab practice has decoupled single-embryo transfer from lower success rates, shifting the commercial opportunity from embryo-number to cost, uterine health, and environmental diagnostics. Investors should reweight toward technologies that cut per-baby cost, expand FET capacity, and address non-oocyte biological risks.
Read more →Why Holistic Medicine Is Returning to the Center of Women's Health in Africa
OURbody founder Chelsea Jambo on why the remedies women passed down for generations were never a quaint alternative to medicine — they were filling gaps a research system built on non-African, non-female bodies never closed.
Read more →McKinsey: Closing the UK's Women's Health Gap Is a £36 Billion Opportunity
A new McKinsey Health Institute report puts a hard number on what Fern has argued since day one: UK women spend 24% more time in poor health than men, and closing that gap could add £36 billion a year to the economy by 2040.
Read more →The Digital Midwife: How Malaica Blends Tech Care with a Human Touch for Expectant Mums
Malaica founder Dr. Lorraine Muluka on why she built a hybrid maternal health platform around a 24/7 nurse-midwife line and a human care team, not a chatbot — and why the postpartum "fourth trimester" gets the same clinical attention as pregnancy itself.
Read more →Impli Awarded £1.4M NIHR Grant to Advance World-First Continuous Hormone Monitoring Patch for Infertility Treatment
The award will fund a 30-month consortium programme bringing together Impli, Imperial College Healthcare NHS Trust, King's College London, and Fertility Europe to take the BEAM biosensor from prototype to first-in-human clinical validation.
Read more →Stay Informed
Women's health is moving fast. Keep up.
Get Fern's latest research, investment commentary, and event invitations delivered to your inbox.